Target intelligence / Profile preview

Staphylococcus aureus SaeRS two-component system (SaeRS)

Target
SaeRS
Molecular classification
Transcription factor, Enzyme, Other
01

Overview

The Staphylococcus aureus SaeRS two-component system is a master regulatory network that controls the expression of numerous virulence factors, including alpha-hemolysin, leukocidins, and coagulase, which are vital for the pathogen's survival and evasion of the host immune system [1.2.1, 1.3.1]. The system consists of the sensor histidine kinase SaeS and the response regulator SaeR, which together sense environmental cues—such as human neutrophil peptides and hydrogen peroxide—to trigger a transcriptional response [1.2.1, 1.3.3]. Upon activation, SaeS autophosphorylates and transfers the phosphate group to SaeR, which then binds to specific DNA sequences to regulate gene expression [1.3.1, 1.3.3]. Because the SaeRS system is essential for staphylococcal pathogenesis but not for basic bacterial growth, it is considered a high-priority target for anti-virulence therapy [1.2.2, 1.4.1]. Inhibitors such as fenoprofen and phenazopyridine have been identified to disrupt this signaling pathway, effectively reducing the production of toxins and enhancing the host's ability to clear the infection [1.2.1, 1.4.3]. This anti-virulence approach aims to disarm the bacteria rather than kill them, potentially reducing the selective pressure for antibiotic resistance [1.4.1, 1.4.3].

Other names
SaeRS two-component systemSae systemSaeR/SStaphylococcus exoprotein expression systemSaeR regulatory system
02

Mechanism of action

Inhibition of sensor kinase autophosphorylation and inhibition of response regulator DNA binding

03

Biological functions

Signal transductionTranscription regulationImmune responseOther
04

Disease associations

Infection
05

Safety considerations

Bacterial resistance developmentLack of bactericidal effectTherapeutic efficacy in complex infections
06

Interacting drugs

Fenoprofen

4 more in the full profile.

07

Biomarkers

Alpha-hemolysin (Hla)Toxic shock syndrome toxin-1 (TSST-1)Coagulase

Beyond the preview

Go deeper on Staphylococcus aureus SaeRS two-component system (SaeRS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus aureus SaeRS two-component system (SaeRS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call